1. Home
  2. INMD vs IVA Comparison

INMD vs IVA Comparison

Compare INMD & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InMode Ltd.

INMD

InMode Ltd.

HOLD

Current Price

$15.62

Market Cap

879.2M

Sector

Health Care

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$5.11

Market Cap

804.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INMD
IVA
Founded
2008
2011
Country
Israel
France
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
879.2M
804.2M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
INMD
IVA
Price
$15.62
$5.11
Analyst Decision
Hold
Strong Buy
Analyst Count
6
7
Target Price
$16.75
$17.14
AVG Volume (30 Days)
563.3K
241.3K
Earning Date
02-03-2026
09-29-2025
Dividend Yield
N/A
N/A
EPS Growth
20.42
N/A
EPS
2.21
N/A
Revenue
$364,494,000.00
$19,929,536.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.76
N/A
P/E Ratio
$7.03
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.14
$2.11
52 Week High
$19.78
$7.98

Technical Indicators

Market Signals
Indicator
INMD
IVA
Relative Strength Index (RSI) 71.55 65.43
Support Level $14.30 $4.48
Resistance Level $14.96 $4.90
Average True Range (ATR) 0.29 0.22
MACD 0.12 0.06
Stochastic Oscillator 92.61 97.14

Price Performance

Historical Comparison
INMD
IVA

About INMD InMode Ltd.

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: